Clinical trial
Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm
NCT07590986 is registered in ClinicalTrials.gov with Université Catholique de Louvain as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm
- Lead sponsor
- Université Catholique de Louvain
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 31, 2026
- Completion date
- January 31, 2037
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
essential thrombocythemia (et), myeloproliferative neoplasm (mpn), polycytemia vera, primary myelofibrosis (pmf)